JCT> Vol.2 No.5, December 2011

 

Copyright © 2011 Shogo Kobayashi, Atsushi Miyamoto, Junzo Shimizu, Masaki Kashiwazaki, Yutaka Takeda, Shigeyuki Ueshima, Yongkook Kim, Toru Kitagawa, Keizo Dono, Masaki Mori, Yuichiro Doki, Hiroaki Nagano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article

---

S. Kobayashi, A. Miyamoto, J. Shimizu, M. Kashiwazaki, Y. Takeda, S. Ueshima, Y. Kim, T. Kitagawa, K. Dono, M. Mori, Y. Doki and H. Nagano, "Comparison of 4-Weekly vs 3-Weekly Gemcitabine as Adjuvant Chemotherapy Following Curative Resection for Biliary Tract Cancer: A Prospective Randomized Controlled Trial," Journal of Cancer Therapy, Vol. 2 No. 5, 2011, pp. 703-709. doi: 10.4236/jct.2011.25095.

 

Download citation as EndNote